BridgeMD
New treatment option for Cardiac Arrest (CA)
Official title A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support
ClinicalTrials.gov ID: NCT06793033
What this study is testing
- What it's testing
- The NEURESCUE device is the first intelligent balloon catheter for aortic balloon occlusion (ABO), an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending to redirect blood flow towards the upper body.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age ≥18 and ≤80 years
- Witnessed arrest
- CPR initiated within 7 min of arrest
- CPR time less than 40 min at enrollment
- Non-shockable rhythm
You likely can't join if
- Traumatic cardiac arrest
- Known pregnancy
- Known terminal disease
- Known do-not-attempt-CPR order
- Known opposition to study participation
The study team makes the final eligibility decision.
Where it's taking place
- Berlin, Germany
- Heidelberg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Berlin, Germany; Heidelberg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.